Dubai, United Arab Emirates: Alliance Global Group and Amgen (Middle East FZ-LLC) have signed an agreement to offer genetic screening for colorectal cancer patients to identify those with mutations in the RAS family of genes.
The agreement establishes a program called "The AGBL-Amgen: RAS Family Screening Program", which calls upon Next Generation Sequencing Technology to sequence mutations of the RAS family of genes using the world's first FDA approved NGS sequencing platform, MiSeq Dx, manufactured by Illumina Inc. of San Diego, CA.
The program aims at better therapeutic outcome to enhance cancer patient management. Starting with Algeria, Saudi Arabia, United Arab Emirates, Egypt and Kuwait, the program will expand to include more countries throughout the Middle East and African region.
Alliance Global Group will work with Amgen Middle East to select and qualify key laboratories throughout the region, provide all necessary instrumentation, training and assay material to perform the sequencing of patients' samples.
"We are quite excited about the AGBL - Amgen RAS program. We believe it brings new hope for many cancer patients across the region and helps in raising the overall treatment outcome for them" Says Dr. Tamer Garawin, the Head of Oncology at Amgen (Middle East FZ-LLC).
About Amgen (Middle East FZ-LLC)
Amgen, a pioneer in biotechnology - headquartered in Southern California, with offices or subsidiaries in more than 30 countries, harnesses the power of cellular and molecular biology and medicinal chemistry to discover develop and deliver innovative human therapeutics. For more than thirty years, Amgen science has generated important medical discoveries, resulting in medicines that have helped millions of patients fight cancer, kidney disease, rheumatoid arthritis, and other serious illnesses. For more information, please visit: www.amgen.com
About Alliance Global Group (AGBL)
The Alliance Global Group is dedicated to bringing innovative technologies and products to researchers, clinicians, and diagnostic users in the emerging healthcare markets. The group has offices across the Middle East, Africa and Asia, and employs a team of scientists and product specialists offering distribution, technical support and consulting services to leading manufacturers of biomedical technologies. The group's stated mission is to improve the lives of the region's inhabitants through novel biomedical technologies and products. For more information, please visit http://www.agbl.net
Alliance Global Group
Arabia | Egypt | Afrique | Maghreb | Pakistan | Asia | Levant | East Africa | South Africa
Contact us on: info@agbl.net
© Press Release 2014
